Bloodwork & longevity telehealth
Which panel to get first, what each one measures, and what happens after the results.
8 providers offer this. 5 include labs in the price. 0 accept insurance. Figures reflect what each provider publishes. * = provisional score.
Highest-scored providers
#1 
InsideTracker 10.0 
Superpower 8.9
InsideTracker 10.0 People focused on nutrition and fitness optimization who want a periodic blood panel with algorithmic recommendations and no prescribing.
Read the review → #2 Superpower 8.9 Cost-conscious adults wanting an annual baseline lab panel plus optional access to prescriptions through the same app, and who accept that medication prices are not published.
Read the review → #3 Marek Health 7.1Data-driven clients who want extensive lab panels and coach-led, provider-supervised hormone optimization, and who will pay out of pocket without a clear upfront total.
Read the review →Ranked guides
All providers
| Clinic | Score | Consult | Labs | Prescriber | Insurance | From |
|---|---|---|---|---|---|---|
| InsideTracker A blood-biomarker and wearable-data platform producing personalised nutrition and lifestyle recommendations. Testing and insights, not treatment. | 10.0 | — | Included | MD/DO | — | $489 first year |
| Superpower An annual-membership health platform combining a broad lab panel with a clinician-reviewed action plan. | 8.9 | Async | Included | MD/DO + NP/PA | Cash | $199/yr |
| Marek Health Also offers A telehealth clinic built around comprehensive bloodwork and physician-guided hormone optimisation, with TRT, peptide therapy and GLP-1 programmes. Known for an unusually deep lab panel. | 7.1 | Hybrid | Extra | MD/DO + NP/PA | Cash | $299 |
 OneTwenty Bloodwork-led longevity and hormone optimisation telehealth, with physician-guided TRT, GLP-1 weight management and peptide therapy built on comprehensive lab panels. | 9.2* | — | Included | — | Cash | $499/yr membership |
 Hone Health Also offers A large men’s hormone telehealth provider offering at-home lab testing, TRT and enclomiphene protocols, with a subscription model and physician video consults. | 6.9* | Video | Extra | MD/DO | Cash | $65 initial lab test |
 Ways2Well Also offers A functional-medicine telehealth clinic offering bloodwork-driven hormone optimisation, TRT, peptide therapy and GLP-1 weight loss. | 6.8* | Video | Included | — | Cash | $125/mo Core care plan |
 Opt Health Also offers A men’s preventive-health telehealth provider combining comprehensive bloodwork with TRT and sexual health treatment under a physician. | 5.4* | Video | Extra | MD/DO + NP/PA | Cash | $95/mo |
 Function Health An annual-membership lab-testing service running a very large biomarker panel with physician-written results summaries. Testing and insights, not treatment. | Not scored | — | Included | — | Cash | $365/yr |
Head-to-head comparisons
InsideTracker vs OneTwentyFunction Health vs InsideTrackerOneTwenty vs SuperpowerFunction Health vs SuperpowerFunction Health vs OneTwentyMarek Health vs OneTwentyHone Health vs Marek HealthFountain TRT vs Marek HealthDefy Medical vs Marek HealthFountain TRT vs Hone HealthHone Health vs MaximusDefy Medical vs Hone Health
Tools for this decision
What these clinics prescribe
Reference records for the compounds offered in this category. Mechanism, dosing ranges, evidence level and regulatory status for each.
- Gonadorelin — Synthetic gonadotropin-releasing hormone, increasingly used alongside TRT to maintain testicular function.
- hCG — A placental glycoprotein hormone that mimics LH directly at the testis, the long-standing standard for preserving fertility on TRT.
- Semaglutide — A long-acting GLP-1 receptor agonist and the compound that reset expectations for pharmacological weight loss.
- Sermorelin — The first 29 amino acids of endogenous growth-hormone-releasing hormone, and the shortest fragment that retains full biological activity.
- Tesamorelin — A stabilised GHRH analog and the only growth-hormone secretagogue with a current FDA approval for a body-composition indication.
- Tirzepatide — A dual GIP and GLP-1 receptor agonist that produced greater weight loss than semaglutide in head-to-head trial data.
References
Regulatory and primary sources
- CMS: Clinical Laboratory Improvement Amendments (CLIA) ↗ · federal standards for clinical labs
- HHS: Telehealth for patients ↗ · what to expect from a telehealth visit
- FDA: BeSafeRx, buying medicine online safely ↗ · how to check an online pharmacy
- NABP: Safe.Pharmacy verified websites ↗ · pharmacy accreditation lookup
- FSMB DocInfo: physician license lookup ↗ · check a prescriber is licensed
- FTC: Endorsements, influencers and reviews ↗ · disclosure rules for affiliate links
Published literature
- Direct-to-consumer genetic testing.BMJ 2019.PubMed 31619392 · doi:10.1136/bmj.l5688
- Direct-to-Consumer Genetic Testing.NEJM Evid 2025.PubMed 41147825 · doi:10.1056/EVIDra2400455
- Direct-to-Consumer Testing: Benefits and Concerns of Commercially Accessed Laboratory Tests.Clin Chem 2025.PubMed 39964351 · doi:10.1093/clinchem/hvaf004
- Home sperm testing-increasing uses for direct-to-consumer tests.Fertil Steril 2023.PubMed 36502933 · doi:10.1016/j.fertnstert.2022.12.010
- Direct-to-Consumer Genetic Testing: Value and Risk.Annu Rev Med 2021.PubMed 32735764 · doi:10.1146/annurev-med-070119-114727
- Direct-to-consumer pharmacogenomic testing.Pharmacogenomics 2011.PubMed 22008043 · doi:10.2217/pgs.11.100
- Direct-to-Consumer Testing.Clin Chem 2017.PubMed 27993938 · doi:10.1373/clinchem.2016.260349
- Direct to consumer testing, drugs and gifts.Bioethics 2020.PubMed 32100331 · doi:10.1111/bioe.12734
Literature retrieved from PubMed on October 18, 2026, favouring human studies and reviews. Numbered markers in the text show which paper supports which statement; uncited entries are background reading.